The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Glycans and glycoproteins as specific biomarkers for cancer
Open accessAbstract
AbstractProtein glycosylation and other post-translational modifications are involved in potentially all aspects of human growth and development. Defective glycosylation has adverse effects on human physiological conditions and accompanies many chronic and infectious diseases. Altered glycosylation can occur at the onset and/or during tumor progression. Identifying these changes at early disease stages may aid in making decisions regarding treatments, as early intervention can greatly enhance survival. This review highlights some of the efforts being made to identify N- and O-glycosylation profile shifts in cancer using mass spectrometry. The analysis of single or panels of potential glycoprotein cancer markers are covered. Other emerging technologies such as global glycan release and site-specific glycosylation analysis and quantitation are also discussed. Graphical AbstractSteps involved in the biomarker discovery
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Eng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484 · cited 1×
“MS analysis generates a tremendous amount of data that requires the development of bioinformatics methods that can aid with data interpretation and expedite the analysis of large data sets [34, 35].”
Estimates of the cancer incidence and mortality in Europe in 2006
Ferlay, J., Autier, P., Boniol, M., Heanue, M., Colombet, M., & Boyle, P. (2007) · Annals of Oncology · doi:10.1093/annonc/mdl498 · Cited by 4,036
Glycosylation in cancer: mechanisms and clinical implications
Pinho, S. S., & Reis, C. A. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3982 · Cited by 3,083
Thompson, A., Schäfer, J., Kuhn, K., Kienle, S., Schwarz, J., Schmidt, G., Neumann, T., & Hamon, C. (2003) · Analytical Chemistry · doi:10.1021/ac0262560 · Cited by 2,378
Proteomic analysis of post-translational modifications
Mann, M., & Jensen, O. N. (2003) · Nature Biotechnology · doi:10.1038/nbt0303-255 · Cited by 2,134
Biomarkers in Cancer Staging, Prognosis and Treatment Selection
Ludwig, J. A., & Weinstein, J. N. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1739 · Cited by 1,666
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
Dube, D. H., & Bertozzi, C. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1751 · Cited by 1,598
Catalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C., Dekernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., et al. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)35233-3 · Cited by 1,592
Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions
Picotti, P., & Aebersold, R. (2012) · Nature Methods · doi:10.1038/nmeth.2015 · Cited by 1,302
Hammarström, S. (1999) · Seminars in Cancer Biology · doi:10.1006/scbi.1998.0119 · Cited by 1,300
Post-translational modifications in the context of therapeutic proteins
Walsh, G., & Jefferis, R. (2006) · Nature Biotechnology · doi:10.1038/nbt1252 · Cited by 1,005
Sawyers, C. L. (2008) · Nature · doi:10.1038/nature06913 · Cited by 983
Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule
Benchimol, S., Fuks, A., Jothy, S., Beauchemin, N., Shirota, K., & Stanners, C. P. (1989) · Cell · doi:10.1016/0092-8674(89)90970-7 · Cited by 974
The CA 125 tumour-associated antigen: a review of the literature
Jacobs, I., & Bast, R. C. (1989) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136832 · Cited by 955
β1-6 Branching of Asn-Linked Oligosaccharides Is Directly Associated with Metastasis
Dennis, J. W., Laferté, S., Waghorne, C., Breitman, M. L., & Kerbel, R. S. (1987) · Science · doi:10.1126/science.2953071 · Cited by 940
Proteomic applications for the early detection of cancer
Wulfkuhle, J. D., Liotta, L. A., & Petricoin, E. F. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1043 · Cited by 907
Mining the plasma proteome for cancer biomarkers
Hanash, S. M., Pitteri, S. J., & Faca, V. M. (2008) · Nature · doi:10.1038/nature06916 · Cited by 891
Anderson, N. L., Anderson, N. G., Haines, L. R., Hardie, D. B., Olafson, R. W., & Pearson, T. W. (2004) · Journal of Proteome Research · doi:10.1021/pr034086h · Cited by 804
Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
Kulasingam, V., & Diamandis, E. P. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1187 · Cited by 771
Byonic: Advanced Peptide and Protein Identification Software
Bern, M., Kil, Y. J., & Becker, C. (2012) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi1320s40 · Cited by 659
Molecular Cloning of the CA125 Ovarian Cancer Antigen
Yin, B. W. T., & Lloyd, K. O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103554200 · Cited by 617
Kaji, H., Saito, H., Yamauchi, Y., Shinkawa, T., Taoka, M., Hirabayashi, J., Kasai, K.-I., Takahashi, N., & Isobe, T. (2003) · Nature Biotechnology · doi:10.1038/nbt829 · Cited by 612
Cell surface protein glycosylation in cancer
Christiansen, M. N., Chik, J., Lee, L., Anugraham, M., Abrahams, J. L., & Packer, N. H. (2014) · PROTEOMICS · doi:10.1002/pmic.201300387 · Cited by 518
Decoding protein modifications using top-down mass spectrometry
Siuti, N., & Kelleher, N. L. (2007) · Nature Methods · doi:10.1038/nmeth1097 · Cited by 503 · cited 1×
“These techniques include electron capture dissociation (ECD), electron transfer dissociation (ETD), and negative electron transfer dissociation (NETD) that retain labile protein modifications in the peptide backbone [124].”
BackgroundAdamczyk, B., Tharmalingam, T., & Rudd, P. M. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.12.001 · Cited by 478
Moertel, C. G. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510080047030 · Cited by 449
Alterations in glycosylation as biomarkers for cancer detection
Reis, C. A., Osorio, H., Silva, L., Gomes, C., & David, L. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2009.071035 · Cited by 432
Glycoproteomics based on tandem mass spectrometry of glycopeptides
Wuhrer, M., Catalina, M. I., Deelder, A. M., & Hokke, C. H. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.09.041 · Cited by 415
A First-Generation Multiplex Biomarker Analysis of Urine for the Early Detection of Prostate Cancer
Laxman, B., Morris, D. S., Yu, J., Siddiqui, J., Cao, J., Mehra, R., Lonigro, R. J., Tsodikov, A., Wei, J. T., Tomlins, S. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3224 · Cited by 409
Wada, Y., Azadi, P., Costello, C. E., Dell, A., Dwek, R. A., Geyer, H., Geyer, R., Kakehi, K., Karlsson, N. G., Kato, K., et al. (2007) · Glycobiology · doi:10.1093/glycob/cwl086 · Cited by 400
Biological Function of Fucosylation in Cancer Biology
Miyoshi, E., Moriwaki, K., & Nakagawa, T. (2007) · Journal of Biochemistry · doi:10.1093/jb/mvn011 · Cited by 395
Ovarian Cancer is Associated with Changes in Glycosylation in Both Acute-Phase Proteins and IgG
Saldova, R., Royle, L., Radcliffe, C. M., Abd Hamid, U. M., Evans, R., Arnold, J. N., Banks, R. E., Hutson, R., Harvey, D. J., Antrobus, R., et al. (2007) · Glycobiology · doi:10.1093/glycob/cwm100 · Cited by 390
Oligosaccharide Analysis by Mass Spectrometry: A Review of Recent Developments
Kailemia, M. J., Ruhaak, L. R., Lebrilla, C. B., & Amster, I. J. (2014) · Analytical Chemistry · doi:10.1021/ac403969n · Cited by 377
Self-citationA list of candidate cancer biomarkers for targeted proteomics.
Polanski, M., & Anderson, N. L. (2007) · PubMed Central · Cited by 350
High-Mannose Glycans are Elevated during Breast Cancer Progression
de Leoz, M. L. A., Young, L. J. T., An, H. J., Kronewitter, S. R., Kim, J., Miyamoto, S., Borowsky, A. D., Chew, H. K., & Lebrilla, C. B. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.002717 · Cited by 320
Self-citationSweetening the Pot: Adding Glycosylation to the Biomarker Discovery Equation
Drake, P. M., Cho, W., Li, B., Prakobphol, A., Johansen, E., Anderson, N. L., Regnier, F. E., Gibson, B. W., & Fisher, S. J. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.136333 · Cited by 302
Okuyama, N., Ide, Y., Nakano, M., Nakagawa, T., Yamanaka, K., Moriwaki, K., Murata, K., Ohigashi, H., Yokoyama, S., Eguchi, H., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21728 · Cited by 293
Determination of glycosylation sites and site-specific heterogeneity in glycoproteins
An, H. J., Froehlich, J. W., & Lebrilla, C. B. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.07.022 · Cited by 280
Self-citationMass spectrometry: from proteomics to metabolomics and lipidomics
Griffiths, W. J., & Wang, Y. (2009) · Chemical Society Reviews · doi:10.1039/b618553n · Cited by 271
An, H. J., Kronewitter, S. R., de Leoz, M. L. A., & Lebrilla, C. B. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.08.015 · Cited by 267
Self-citationMass Spectrometry and the Emerging Field of Glycomics
Zaia, J. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.07.016 · Cited by 248
Panel of Serum Biomarkers for the Diagnosis of Lung Cancer
Patz, E. F., Campa, M. J., Gottlin, E. B., Kusmartseva, I., Guan, X. R., & Herndon, J. E. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.5392 · Cited by 247
Breast Cancer Diagnosis and Prognosis through Quantitative Measurements of Serum Glycan Profiles
Kyselova, Z., Mechref, Y., Kang, P., Goetz, J. A., Dobrolecki, L. E., Sledge, G. W., Schnaper, L., Hickey, R. J., Malkas, L. H., & Novotny, M. V. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.087148 · Cited by 246
Powers, T. W., Neely, B. A., Shao, Y., Tang, H., Troyer, D. A., Mehta, A. S., Haab, B. B., & Drake, R. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106255 · Cited by 244
Alterations in the Serum Glycome Due to Metastatic Prostate Cancer
Kyselova, Z., Mechref, Y., Al Bataineh, M. M., Dobrolecki, L. E., Hickey, R. J., Vinson, J., Sweeney, C. J., & Novotny, M. V. (2007) · Journal of Proteome Research · doi:10.1021/pr060664t · Cited by 231
Profiling of Glycans in Serum for the Discovery of Potential Biomarkers for Ovarian Cancer
An, H. J., Miyamoto, S., Lancaster, K. S., Kirmiz, C., Li, B., Lam, K. S., Leiserowitz, G. S., & Lebrilla, C. B. (2006) · Journal of Proteome Research · doi:10.1021/pr060010k · Cited by 226
Self-citationA Serum Glycomics Approach to Breast Cancer Biomarkers
Kirmiz, C., Li, B., An, H. J., Clowers, B. H., Chew, H. K., Lam, K. S., Ferrige, A., Alecio, R., Borowsky, A. D., Sulaimon, S., et al. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600171-mcp200 · Cited by 225
Self-citationGlycomics: a pathway to a class of new and improved therapeutics
Shriver, Z., Raguram, S., & Sasisekharan, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1521 · Cited by 220
Drake, R. R., Schwegler, E. E., Malik, G., Diaz, J., Block, T., Mehta, A., & Semmes, O. J. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600176-mcp200 · Cited by 216
The State of Molecular Biomarkers for the Early Detection of Lung Cancer
Hassanein, M., Callison, J. C., Callaway-Lane, C., Aldrich, M. C., Grogan, E. L., & Massion, P. P. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0441 · Cited by 215
Ralhan, R., DeSouza, L. V., Matta, A., Chandra Tripathi, S., Ghanny, S., Datta Gupta, S., Bahadur, S., & Siu, K. W. M. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700500-mcp200 · Cited by 215
Zhao, J., Simeone, D. M., Heidt, D., Anderson, M. A., & Lubman, D. M. (2006) · Journal of Proteome Research · doi:10.1021/pr060034r · Cited by 214
Protein glycosylation analysis by liquid chromatography–mass spectrometry
WUHRER, M., DEELDER, A., & HOKKE, C. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.01.030 · Cited by 205
Oligosaccharide analysis by graphitized carbon liquid chromatography–mass spectrometry
Ruhaak, L. R., Deelder, A. M., & Wuhrer, M. (2009) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-009-2664-5 · Cited by 201
N-linked Glycan Structures and Their Expressions Change in the Blood Sera of Ovarian Cancer Patients
Alley, W. R., Vasseur, J. A., Goetz, J. A., Svoboda, M., Mann, B. F., Matei, D. E., Menning, N., Hussein, A., Mechref, Y., & Novotny, M. V. (2012) · Journal of Proteome Research · doi:10.1021/pr201070k · Cited by 192
A List of Candidate Cancer Biomarkers for Targeted Proteomics
Polanski, M., & Anderson, N. L. (2006) · Biomarker Insights · doi:10.1177/117727190600100001 · Cited by 189
Saldova, R., Fan, Y., Fitzpatrick, J. M., Watson, R. W. G., & Rudd, P. M. (2011) · Glycobiology · doi:10.1093/glycob/cwq147 · Cited by 188
Protein microarray detection strategies: focus on direct detection technologies
Espina, V., Woodhouse, E. C., Wulfkuhle, J., Asmussen, H. D., Petricoin, E. F., & Liotta, L. A. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.04.013 · Cited by 186
Ihara, S., Miyoshi, E., Ko, J. H., Murata, K., Nakahara, S., Honke, K., Dickson, R. B., Lin, C.-Y., & Taniguchi, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200673200 · Cited by 175
Proteomic Analysis to Identify Breast Cancer Biomarkers in Nipple Aspirate Fluid
Alexander, H., Stegner, A. L., Wagner-Mann, C., Du Bois, G. C., Alexander, S., & Sauter, E. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1002 · Cited by 175
Glycosylation Characteristics of Colorectal Cancer
Holst, S., Wuhrer, M., & Rombouts, Y. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2014.11.004 · Cited by 173
Glycopeptide analysis by mass spectrometry
Dalpathado, D. S., & Desaire, H. (2008) · The Analyst · doi:10.1039/b713816d · Cited by 169
Cancer Antigen 125 Associated With Multiple Benign and Malignant Pathologies
Miralles, C., Orea, M., Espa�a, P., Provencio, M., S�nchez, A., Cantos, B., Cubedo, R., Carcereny, E., Bonilla, F., & Gea, T. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.05.015 · Cited by 166
Pagel, O., Loroch, S., Sickmann, A., & Zahedi, R. P. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2015.1042867 · Cited by 164
N-glycosylation of Colorectal Cancer Tissues
Balog, C. I. A., Stavenhagen, K., Fung, W. L. J., Koeleman, C. A., McDonnell, L. A., Verhoeven, A., Mesker, W. E., Tollenaar, R. A. E. M., Deelder, A. M., & Wuhrer, M. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.011601 · Cited by 164
Transcriptional Regulation ofN-Acetylglucosaminyltransferase V by the srcOncogene
Buckhaults, P., Chen, L., Fregien, N. L., & Pierce, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19575 · Cited by 161
Alley, W. R., Maděra, M., Mechref, Y. S., & Novotný, M. V. (2010) · Analytical Chemistry · doi:10.1021/ac100131e · Cited by 157
Hua, S. S., An, H. J., Özcan, S., Ro, G. S., Soares, S., White, R. D., & Lebrilla, C. B. (2011) · The Analyst · doi:10.1039/c1an15093f · Cited by 154
Self-citationChu, C. S., Niñonuevo, M. R., Clowers, B. H., Perkins, P. D., An, H. J., Yin, H., Killeen, K., Miyamoto, S., Grimm, R., & Lebrilla, C. B. (2009) · PROTEOMICS · doi:10.1002/pmic.200800249 · Cited by 152
Self-citationDevelopments in the Identification of Glycan Biomarkers for the Detection of Cancer
Ruhaak, L. R., Miyamoto, S., & Lebrilla, C. B. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r112.026799 · Cited by 150
Self-citationCA 15–3: A Prognostic Marker in Breast Cancer
Duffy, M. J., Shering, S. G., Sherry, F., McDermott, E. W. M., & O’Higgins, N. J. (2000) · The International Journal of Biological Markers · doi:10.1177/172460080001500410 · Cited by 142
Mass spectrometry-based clinical proteomics
Pusch, W., Flocco, M. T., Leung, S.-M., Thiele, H., & Kostrzewa, M. (2003) · Pharmacogenomics · doi:10.1517/phgs.4.4.463.22753 · Cited by 134
Wu, J., Xie, X., Liu, Y., He, J., Benitez, R. S., Buckanovich, R. J., & Lubman, D. M. (2012) · Journal of Proteome Research · doi:10.1021/pr300330z · Cited by 132
Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis
Nie, S., Lo, A., Wu, J., Zhu, J., Tan, Z., Simeone, D. M., Anderson, M. A., Shedden, K. A., Ruffin, M. T., & Lubman, D. M. (2014) · Journal of Proteome Research · doi:10.1021/pr400967x · Cited by 128
Simultaneous and Extensive Site-specific N- and O-Glycosylation Analysis in Protein Mixtures
Nwosu, C. C., Seipert, R. R., Strum, J. S., Hua, S. S., An, H. J., Zivkovic, A. M., German, B. J., & Lebrilla, C. B. (2011) · Journal of Proteome Research · doi:10.1021/pr2001429 · Cited by 125
Self-citationHuang, H., Stasyk, T., Morandell, S., Dieplinger, H., Falkensammer, G., Griesmacher, A., Mogg, M., Schreiber, M., Feuerstein, I., Huck, C. W., et al. (2006) · Electrophoresis · doi:10.1002/elps.200500857 · Cited by 123
Absolute Quantitation of Immunoglobulin G and Its Glycoforms Using Multiple Reaction Monitoring
Hong, Q., Lebrilla, C. B., Miyamoto, S., & Ruhaak, L. R. (2013) · Analytical Chemistry · doi:10.1021/ac4009995 · Cited by 116
Self-citationAhmed, N., Barker, G., Oliva, K., Hoffmann, P., Riley, C. B., Reeve, S. B., Smith, A. I., Kemp, B. E., Quinn, M. A., & Rice, G. E. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601882 · Cited by 114
Kuno, A., Kato, Y., Matsuda, A., Kaneko, M. K., Ito, H., Amano, K., Chiba, Y., Narimatsu, H., & Hirabayashi, J. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800308-mcp200 · Cited by 114
Altered Glycosylation in Prostate Cancer
Drake, R. R., Jones, E. E., Powers, T. W., & Nyalwidhe, J. O. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2014.12.001 · Cited by 111
Plasma Protein Profiling by Mass Spectrometry for Cancer Diagnosis: Opportunities and Limitations
Diamandis, E. P., & van der Merwe, D. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.963.11.3 · Cited by 111
Miyoshi, E., & Nakano, M. (2008) · PROTEOMICS · doi:10.1002/pmic.200800046 · Cited by 111
Targeted Glycoproteomic Identification of Biomarkers for Human Breast Carcinoma
Abbott, K. L., Aoki, K., Lim, J., Porterfield, M., Johnson, R. W., O'Regan, R. M., Wells, L., Tiemeyer, M., & Pierce, M. (2008) · Journal of Proteome Research · doi:10.1021/pr700792g · Cited by 101
Ahn, Y. H., Lee, J. Y., Lee, J. Y., Kim, Y.-S., Ko, J. H., & Yoo, J. S. (2009) · Journal of Proteome Research · doi:10.1021/pr900269s · Cited by 94
Proteoglycomics: Recent Progress and Future Challenges
Ly, M., Laremore, T. N., & Linhardt, R. J. (2010) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2009.0123 · Cited by 92
Computational Framework for Identification of Intact Glycopeptides in Complex Samples
Mayampurath, A. M., Yu, C., Song, E., Balan, J., Mechref, Y. S., & Tang, H. (2013) · Analytical Chemistry · doi:10.1021/ac402338u · Cited by 91
Clinical Glycomics Employing Graphitized Carbon Liquid Chromatography–Mass Spectrometry
Stavenhagen, K., Kolarich, D., & Wuhrer, M. (2014) · Chromatographia · doi:10.1007/s10337-014-2813-7 · Cited by 90
Šanda, M., Pompach, P., Brnáková, Z., Wu, J., Makambi, K. H., & Goldman, R. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.023325 · Cited by 88
Mass spectrometry in clinical proteomics – from the present to the future
Palmblad, M., Tiss, A., & Cramer, R. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200800090 · Cited by 84
Lin, H., Xin, L., Shan, B., Lajoie, G., & Ma, B. (2014) · Journal of Proteome Research · doi:10.1021/pr401115y · Cited by 84
Tan, Z., Yin, H., Nie, S., Lin, Z., Zhu, J., Ruffin, M. T., Anderson, M. A., Simeone, D. M., & Lubman, D. M. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00068 · Cited by 83
Zhao, C., Loganath, A., Guo, C., Narasimhan, K., Koh, S. C. L., Zhang, H., Biswas, A., & Choolani, M. A. (2007) · Neoplasia · doi:10.1593/neo.06619 · Cited by 82
Global methods for protein glycosylation analysis by mass spectrometry
Budnik, B., Lee, R. S., & Steen, J. A. J. (2006) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2006.10.005 · Cited by 81
A Method for Comprehensive Glycosite-Mapping and Direct Quantitation of Serum Glycoproteins
Hong, Q., Ruhaak, L. R., Stroble, C., Parker, E. A., Huang, J., Maverakis, E. M., & Lebrilla, C. B. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00756 · Cited by 79
Self-citationLeoz, M. L. A. D., An, H. J., Kronewitter, S. R., Kim, J., Beecroft, S., Vinall, R. L., Miyamoto, S., White, R. D., Lam, K. S., & Lebrilla, C. B. (2008) · Disease Markers · doi:10.1155/2008/515318 · Cited by 78
Self-citationSong, E., Pyreddy, S., & Mechref, Y. S. (2012) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.6290 · Cited by 78
Strum, J. S., Nwosu, C. C., Hua, S. S., Kronewitter, S. R., Seipert, R. R., Bachelor, R. J., An, H. J., & Lebrilla, C. B. (2013) · Analytical Chemistry · doi:10.1021/ac4006556 · Cited by 76
Self-citationProtein-Specific Differential Glycosylation of Immunoglobulins in Serum of Ovarian Cancer Patients
Ruhaak, L. R., Kim, K., Stroble, C., Taylor, S. L., Hong, Q., Miyamoto, S., Lebrilla, C. B., & Leiserowitz, G. S. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b01071 · Cited by 76
Self-citationYuan, W., Šanda, M., Wu, J., Koomen, J. M., & Goldman, R. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2014.12.020 · Cited by 73
Ueda, K., Takami, S., Saichi, N., Daigo, Y., Ishikawa, N., Kohno, N., Katsumata, M., Yamane, A., Ota, M., Sato, T., et al. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.000893 · Cited by 73
Advances in Proximal Fluid Proteomics for Disease Biomarker Discovery
Teng, P.-N., Bateman, N. W., Hood, B. L., & Conrads, T. P. (2010) · Journal of Proteome Research · doi:10.1021/pr100904q · Cited by 73
Mayampurath, A. M., Wu, Y., Segu, Z. M., Mechref, Y. S., & Tang, H. (2011) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.5059 · Cited by 70
A Method for In-Depth Structural Annotation of Human Serum Glycans That Yields Biological Variations
Song, T., Aldredge, D. L., & Lebrilla, C. B. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b01340 · Cited by 67
Self-citationReid, G. E., Stephenson, J. L., & McLuckey, S. A. (2001) · Analytical Chemistry · doi:10.1021/ac015618l · Cited by 64
Software for automated interpretation of mass spectrometry data from glycans and glycopeptides
Woodin, C. L., Maxon, M., & Desaire, H. (2012) · The Analyst · doi:10.1039/c2an36042j · Cited by 64
Mass spectrometry-based N-glycoproteomics for cancer biomarker discovery
Zhang, Y., Jiao, J., Yang, P., & Lu, H. (2014) · Clinical Proteomics · doi:10.1186/1559-0275-11-18 · Cited by 63
Application of Nano-LC-Based Glycomics Towards Biomarker Discovery
Hua, S. S., Lebrilla, C. B., & An, H. J. (2011) · Bioanalysis · doi:10.4155/bio.11.263 · Cited by 60
Self-citationÁlvarez-Manilla, G., Warren, N. L., Atwood, J., Orlando, R., Dalton, S., & Pierce, M. (2009) · Journal of Proteome Research · doi:10.1021/pr8007489 · Cited by 59
The serum immunoglobulin G glycosylation signature of gastric cancer
Ruhaak, L. R., Barkauskas, D. A., Torres, J., Cooke, C. L., Wu, L. D., Stroble, C., Özcan, S., Williams, C. C., Camorlinga, M., Rocke, D. M., et al. (2014) · EuPA Open Proteomics · doi:10.1016/j.euprot.2014.11.002 · Cited by 58
Self-citationYin, H., Lin, Z., Nie, S., Wu, J., Tan, Z., Zhu, J., Dai, J., Feng, Z., Marrero, J. A., & Lubman, D. M. (2014) · Journal of Proteome Research · doi:10.1021/pr500043k · Cited by 54
Jiménez, C. R., & Verheul, H. M. W. (2014) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2014.34.e504 · Cited by 51
Kronewitter, S. R., Leoz, M. L. A. D., Strum, J. S., An, H. J., Dimapasoc, L. M., Guerrero, A., Miyamoto, S., Lebrilla, C. B., & Leiserowitz, G. S. (2012) · PROTEOMICS · doi:10.1002/pmic.201100273 · Cited by 48
Self-citationConfident Assignment of Site-Specific Glycosylation in Complex Glycoproteins in a Single Step
Khatri, K., Staples, G. O., Leymarie, N., Leon, D. R., Turiák, L., Huang, Y., Yip, S. H., Hu, H., Heckendorf, C. F., & Zaia, J. (2014) · Journal of Proteome Research · doi:10.1021/pr500506z · Cited by 47
A Glycomics Approach to the Discovery of Potential Cancer Biomarkers
An, H. J., & Lebrilla, C. B. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-454-8_14 · Cited by 45
Self-citationProteomics as a Tool for Biomarker Discovery
Kohn, E. C., Azad, N. S., Annunziata, C. M., Dhamoon, A. S., & Whiteley, G. (2007) · Disease Markers · doi:10.1155/2007/967023 · Cited by 45
Glycoproteomic strategies: From discovery to clinical application of cancer carbohydrate biomarkers
Ueda, K. (2013) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201200123 · Cited by 45
Enrichment Strategies for Glycopeptides
Ito, S., Hayama, K., & Hirabayashi, J. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-022-5_14 · Cited by 45
Lam, Y. W., Mobley, J. A., Evans, J. E., Carmody, J., & Ho, S. (2005) · PROTEOMICS · doi:10.1002/pmic.200401165 · Cited by 43
Li, Y., Wen, T., Zhu, M., Li, L., Wei, J., Wu, X., Guo, M., Liu, S., Zhao, H., Xia, S., et al. (2013) · Molecular BioSystems · doi:10.1039/c3mb00013c · Cited by 35
Kanoh, Y., Mashiko, T., Danbara, M., Takayama, Y., Ohtani, S., Imasaki, T., Abe, T., & Akahoshi, T. (2004) · Oncology · doi:10.1159/000079484 · Cited by 34
Functional Impact of Tumor-Specific N-Linked Glycan Changes in Breast and Ovarian Cancers
Guo, H., & Abbott, K. L. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2014.11.006 · Cited by 33
Absolute Quantitation of Glycosylation Site Occupancy Using Isotopically Labeled Standards and LC-MS
Zhu, Z., Go, E. P., & Desaire, H. (2014) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-014-0859-2 · Cited by 32
Applications of Multiple Reaction Monitoring to Clinical Glycomics
Ruhaak, L. R., & Lebrilla, C. B. (2014) · Chromatographia · doi:10.1007/s10337-014-2783-9 · Cited by 29
Self-citationSerum Glycans as Risk Markers for Non–Small Cell Lung Cancer
Ruhaak, L. R., Stroble, C., Dai, J., Barnett, M. J., Taguchi, A., Goodman, G. E., Miyamoto, S., Gandara, D. R., Feng, Z., Lebrilla, C. B., et al. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0033 · Cited by 27
Self-citationLin, Z., Yin, H., Lo, A., Ruffin, M. T., Anderson, M. A., Simeone, D. M., & Lubman, D. M. (2013) · Electrophoresis · doi:10.1002/elps.201300376 · Cited by 26
Gbormittah, F. O., Bones, J., Hincapie, M., Tousi, F., Hancock, W. S., & Iliopoulos, O. (2015) · Journal of Proteome Research · doi:10.1021/pr501104j · Cited by 26
Hecht, E. S., Scholl, E. H., Walker, S. H., Taylor, A. D., Cliby, W. A., Motsinger‐Reif, A. A., & Muddiman, D. C. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00703 · Cited by 26
Mass Spectrometry-Based Biomarkers in Drug Development
Robinson, M., Miller, R. A., & Spellman, D. S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-15950-4_25 · Cited by 13
Mass spectrometry-based biomarkers in drug development.
Miller, R. A., & Spellman, D. S. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-06068-2_16 · Cited by 13
Cited by
Insights into the role of sialylation in cancer progression and metastasis
Dobie, C., & Skropeta, D. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01126-7 · Cited by 348
Bodaghi, A., Fattahi, N., & Ramazani, A. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13323 · Cited by 336
RetractedProtein Glycosylation and Tumor Microenvironment Alterations Driving Cancer Hallmarks
Peixoto, A., Relvas-Santos, M., Azevedo, R., Santos, L. L., & Ferreira, J. A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00380 · Cited by 334
Metadata
- Authors
- Kailemia, M. J., Park, D., & Lebrilla, C. B.
- Venue
- Analytical and Bioanalytical Chemistry
- Published
- 2016-09-03
- Volume
- 409
- Issue
- 2
- Pages
- 395-410
- ISSN
- 1618-2642 (ISSN-L)
- 1618-2650
- OpenAlex
- W2512344700
- Cited by
- 341
- References
- 134
- FWCI
- 16.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.